Home › Atrial Fibrillation › Michigan › Lansing
Atrial Fibrillation clinical trials in Lansing, MI
3 studies for Atrial Fibrillation are looking for participants at sites in and around Lansing (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
RecruitingObservational study
- Sparrow Clinical Research, Lansing
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
RecruitingPhase 3
- Anthos Investigational site 9819, Lansing
- Anthos Investigative Site 1021, Lansing
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
RecruitingObservational study
- Sparrow Clinical Research Institute, Lansing
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- New York City, NY21 studies
- Boston, MA17 studies
- Cleveland, OH17 studies
- Atlanta, GA16 studies
- Jonesboro, AR12 studies
- Philadelphia, PA12 studies
- Chicago, IL12 studies
- Ann Arbor, MI11 studies
- Columbus, OH10 studies
- Cincinnati, OH10 studies
- Pittsburgh, PA10 studies
- Austin, TX9 studies
Other studies in Lansing
- Lung Cancer11 studies
- Prostate Cancer10 studies
- Breast Cancer10 studies
- Non-Small Cell Lung Cancer9 studies
- Cancer (all types)6 studies
- Laryngeal Cancer5 studies
- Bladder Cancer5 studies
- Disorders of Excessive Somnolence5 studies
- Colorectal Cancer4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Colon Cancer4 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.